荷兰特应性皮炎与银屑病共同决策的现状与需求:患者与医生的在线调查研究
该研究通过在线调查评估荷兰特应性皮炎(AD)和银屑病治疗决策中共同决策(SDM)的应用程度。分析219例患者和147例医生的应答发现,皮肤科医生感知的SDM显著高于患者(SDM-Q 82 vs 55;P < 0.01),多数患者和医生倾向共享决策,主要促进因素为双方对SDM的积极态度,障碍包括缺乏同一医生的连续性照护和缺乏时间。结论认为患者体验到的SDM有限,需要改善。
要点
- 皮肤科医生感知的SDM显著高于患者(SDM-Q 82 vs 55;P < 0.01)。
- 多数患者和皮肤科医生倾向共享治疗决策。
- SDM主要障碍为缺乏同一医生的连续性照护和缺乏时间。
核心结论
- 尽管皮肤科医生视角乐观,但患者体验到的SDM程度有限,医生应意识到这一差距。
- AD和银屑病中需要改善SDM。
- 患者和医生对SDM过程和结果的积极态度是重要促进因素,障碍主要在组织层面。
研究设计与样本
- 两项相似的在线调查,一项针对AD或银屑病患者,一项针对(住院)皮肤科医生。
- 调查包含已验证问卷(SDM-Q;范围0-100;Control Preference Scale)和关于SDM障碍与促进因素的研究特定陈述。
- 分析219例患者和147例医生的应答。
主要发现
- 皮肤科医生体验到的SDM显著多于患者(SDM-Q 82 vs 55;P < 0.01)。
- 多数患者和皮肤科医生偏好共享治疗决策。
- 主要促进因素包括患者和皮肤科医生对SDM的积极感知。
- 感知的障碍包括缺乏同一医生的连续性照护和缺乏时间。
关键数值与推荐
- SDM-Q评分范围0-100,皮肤科医生82 vs 患者55,P < 0.01。
临床怎么用
- 皮肤科医生应意识到患者体验到的SDM可能低于自身感知,主动评估并促进共享决策。
- 针对AD和银屑病偏好敏感的治疗决策,应鼓励患者参与共享决策。
- 改善组织层面因素如连续性照护和时间安排,以减少SDM障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In shared decision making (SDM), patients and physicians work together to choose the best treatment option for an individual patient. Atopic dermatitis (AD) and psoriasis are particularly suitable for SDM, considering that the best treatment option depends on a patient's preferences and values (preference-sensitive decisions). Currently, it is unknown to what extent SDM is applied in treatment decisions for these diseases in the Netherlands. OBJECTIVES: Primary, to assess the current extent of SDM in AD and psoriasis in the Netherlands amongst patients and dermatologists. Secondary, to assess the degree to which patients and physicians endorse SDM, to explore which characteristics are related to their preference to be involved in SDM and to identify which barriers and facilitators for SDM they perceive. METHODS: Two similar online surveys, one for patients with AD or psoriasis and one for (resident) dermatologists, were carried out. The surveys comprised validated questionnaires (shared decision making questionnaire (SDM-Q; range 0-100), Control Preference Scale) and study-specific statements mainly regarding barriers and facilitators for SDM. RESULTS: The responses of 219 patients and 147 physicians were analysed. Dermatologists experienced significantly more SDM than patients (SDM-Q 82 vs 55; P < 0.01). Most patients and dermatologists prefer to share treatment decisions. Mainly facilitators for SDM were perceived, including the positive perception of patients and dermatologists regarding SDM. The perceived barriers included lack of continuity of care by the same physician and lack of time. CONCLUSION: Despite the dermatologists' optimistic perspective, patients experience a limited extent of SDM and physicians should be aware of this gap. Improvement of SDM in AD and psoriasis is needed. The positive attitude of patients and dermatologists towards the process and outcome of SDM is important facilitators, while barriers were mainly perceived on an organizational level.
引用
- van der Kraaij GE, Vermeulen FM, Smeets PMG, et al. The current extent of and need for shared decision making in atopic dermatitis and psoriasis in the Netherlands: an online survey study amongst patients and physicians. J Eur Acad Dermatol Venereol. 2020. PMID: 32163645. doi:10.1111/jdv.16340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。